Detection and Optimization of Cardiac Markers Based on High Sensitivity C-Reactive Protein
Keywords:
Heart Marker, High Sensitivity C-reactive Protein, Detection Method, Myocardial Infarction
Abstract
Cardiac markers play an important role in prognosis and follow-up treatment. Therefore, it is of great practical significance to study the detection methods of high-sensitivity C-reactive protein cardiac markers. The purpose of this paper is to study the optimal method for the detection of cardiac markers of high-sensitivity C-reactive protein. In this paper, the significance of cardiac markers and high-sensitivity C-reactive protein and the relationship between them and myocardial infarction were first described. The BCA method for the purification and identification of C-reactive protein was studied, and then the determination and optimization of high-sensitivity C-reactive protein and high-sensitivity C-reactive protein in healthy people were further understood. To explore the application of serum high sensitive C-reactive protein in the detection of cardiac markers in 50 patients with acute myocardial infarction and 50 healthy people. The results showed that the experimental group was (21.57 ± 1.50), (37.62 ± 1.66), (529.20 ± 5.72), (95.79 ± 6.24) ng / ml, the control group was (0.90 ± 1.10), (1.71 ± 0.14), (35.25 ± 4.21), (0.99 ± 0.71) ng / ml, and the difference between the two groups was statistically significant (P < 0.05).References
[1] Laura CT, Eliana M, MarÃa S, et al. Detection of reactive oxygen and nitrogen species (ROS/RNS) during hypersensitive cell death. Plant Programmed Cell Death 2018; 116(6): 97-105. doi: 10.1007/978-1-4939-7668-3_9.
[2] Masayuki T. High-sensitive C-reactive protein in primary aldosteronism. Journal of Hypertension 2017; 35(1): 200. doi:10.1097/HJH.0000000000001163.
[3] Reihane J, Elham K. Level of high sensitive C-reactive protein and procalcitonin in pregnant women with mild and severe preeclampsia. Advanced Biomedical Research 2017; 6(1): 140. doi: 10.4103/2277-9175.218032.
[4] Luigi R, Nick AB, Antoine M. Ultra-high sensitive C-reactive protein during normal pregnancy and in preeclampsia: a pilot study. Journal of Hypertension 2019; 37(5): 1. doi: 10.1097/HJH.0000000000002003.
[5] L. Ziyun, L. Bo, J. Ye. Association between serum uric acid levels and high sensitive C-reactive protein in patients with type 2 diabetes. Zhonghua Yi Xue Za Zhi 2017; 97(28): 2181-2185. doi: 10.3760/cma.j.issn.0376-2491.2017.28.005.
[6] Boyapati R, Chinthalapani S, Ramisetti A, et al. Association of pentraxin and high-sensitive C-reactive protein as inflammatory biomarkers in patients with chronic periodontitis and peripheral arterial disease. Journal of Indian Society of Periodontology 2018; 22(2): 112-115.
[7] Aidin L, Behzad E. The role of supplements in reducing cardiovascular events by decrease in highly sensitive C-reactive protein and serum homocysteine. Saudi Journal of Kidney Diseases & Transplantation 2017; 28(6): 1451. doi: 10.4103/1319-2442.220853.
[8] Kaur M. C-reactive protein: A prognostic indicator. International Journal of Applied & Basic Medical Research 2017; 7(2): 83-84. doi: 10.4103/ijabmr.IJABMR_63_17.
[9] Dimitrios V, Nikolaos P, Ioanna K. C-reactive protein and frailty in the elderly: A literature review. Journal of Clinical Medicine Research 2017; 9(6): 461-465. doi: 10.14740/jocmr2959w.
[10] Sujaya G, Shaili P, Sushil K. C-reactive protein in periodontitis and its comparison with body mass index and smoking behaviour. Journal of the Nepal Medical Association 2017; 55(206): 226-233. doi: 10.31729/jnma.3134.
[11] Jonathan B, Chris TL. Heart fat in HIV: Marker or mediator of risk?. Current Opinion in Hiv & Aids 2017; 12(6): 1. doi: 10.1097/COH.0000000000000414.
[12] Moczulska B, Kubiak M, Bryczkowska A, et al. Pulse wave velocity as an early marker of diastolic heart failure in patients with hypertension. Polski Merkuriusz Lekarski Organ Polskiego 2017; 42(250): 142-144.
[2] Masayuki T. High-sensitive C-reactive protein in primary aldosteronism. Journal of Hypertension 2017; 35(1): 200. doi:10.1097/HJH.0000000000001163.
[3] Reihane J, Elham K. Level of high sensitive C-reactive protein and procalcitonin in pregnant women with mild and severe preeclampsia. Advanced Biomedical Research 2017; 6(1): 140. doi: 10.4103/2277-9175.218032.
[4] Luigi R, Nick AB, Antoine M. Ultra-high sensitive C-reactive protein during normal pregnancy and in preeclampsia: a pilot study. Journal of Hypertension 2019; 37(5): 1. doi: 10.1097/HJH.0000000000002003.
[5] L. Ziyun, L. Bo, J. Ye. Association between serum uric acid levels and high sensitive C-reactive protein in patients with type 2 diabetes. Zhonghua Yi Xue Za Zhi 2017; 97(28): 2181-2185. doi: 10.3760/cma.j.issn.0376-2491.2017.28.005.
[6] Boyapati R, Chinthalapani S, Ramisetti A, et al. Association of pentraxin and high-sensitive C-reactive protein as inflammatory biomarkers in patients with chronic periodontitis and peripheral arterial disease. Journal of Indian Society of Periodontology 2018; 22(2): 112-115.
[7] Aidin L, Behzad E. The role of supplements in reducing cardiovascular events by decrease in highly sensitive C-reactive protein and serum homocysteine. Saudi Journal of Kidney Diseases & Transplantation 2017; 28(6): 1451. doi: 10.4103/1319-2442.220853.
[8] Kaur M. C-reactive protein: A prognostic indicator. International Journal of Applied & Basic Medical Research 2017; 7(2): 83-84. doi: 10.4103/ijabmr.IJABMR_63_17.
[9] Dimitrios V, Nikolaos P, Ioanna K. C-reactive protein and frailty in the elderly: A literature review. Journal of Clinical Medicine Research 2017; 9(6): 461-465. doi: 10.14740/jocmr2959w.
[10] Sujaya G, Shaili P, Sushil K. C-reactive protein in periodontitis and its comparison with body mass index and smoking behaviour. Journal of the Nepal Medical Association 2017; 55(206): 226-233. doi: 10.31729/jnma.3134.
[11] Jonathan B, Chris TL. Heart fat in HIV: Marker or mediator of risk?. Current Opinion in Hiv & Aids 2017; 12(6): 1. doi: 10.1097/COH.0000000000000414.
[12] Moczulska B, Kubiak M, Bryczkowska A, et al. Pulse wave velocity as an early marker of diastolic heart failure in patients with hypertension. Polski Merkuriusz Lekarski Organ Polskiego 2017; 42(250): 142-144.
Published
2020-02-16
Issue
Section
Original Research Article
Copyright (c) 2020 Chen Dai
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.
